MilliporeSigma was commissioned to perform the technology transfer and optimization of bioprocess chemistry and associated analytical methods for the production of antibody-drug conjugate ADC-X.
Connecting processes can be considered the next stage in evolution for biopharma manufacture, but how should companies approach the challenges?
Securing a partner to serve as an extension of Janssen’s Biotherapeutics Development API-Large Molecule team was essential to reducing both risk and the time needed for delivery of critical clinical supplies.
By applying remote monitoring solutions, advanced modeling, and optimization of manufacturing processes, Industry 4.0 offers improved process reliability and product quality through unlimited possibilities of connecting machines and data.
Using its Supplier Relationship Excellence (SRE) program, Amgen opened the lines of communication with suppliers and created a feedback loop where data can be shared to better understand operational performance.
Companies must understand how today’s new pharmaceutical landscape is causing a dramatic shift in how we plan for and execute drug development and manufacturing.
An overview of Libbs product portfolio and how they benefit from Thermo Fisher Scientific services.
See how GE Healthcare products that are currently used in the cell processing workflow for cell therapy.
Leaders address how next generation processing will have a significant impact on how therapies are brought to market, delivering them to patients faster and more cost-effectively than ever before.
Watch experts discuss best practices that can help you manage supply chain risks.
Millipore offers a broad range of single-use equipment, custom designed with our experts to meet the challenging needs of ADC production.
Explore an approach to interpret the extractables data generated for single-use components used in biopharmaceutical processes by adopting the BPOG (BioPhorum Operations Group) protocol as a baseline testing strategy.
Flexible, reliable control and bioreactor systems for laboratory applications
Thermo Scientific™ HyPerforma™ bioprocess control systems are designed to optimize your process from the laboratory bench to full cGMP manufacturing. Our innovative control platform combines a flexible operating system with scalable, modular hardware, novel single-use sensors, and state-of-the-art bioreactors for strategic and streamlined bioprocess control.
HyPerforma benchtop solutions offer robust management of both cell culture and fermentation processes. The open architecture provides process flexibility, and dedicated hardware control allows for expansion. Thermo Scientific™ TruBio™ software is designed to support easy process control and scaling.
Flexible, reliable control and bioreactor systems for laboratory applications.
Current demand for sterile injectable drug product manufacturing is fed by multiple dynamics, and when the decision has been made to outsource there is a spectrum of options: niche CMOs with a sterile-injectable focus, large CMOs with end-to-end services for a variety of dosage forms, and one-stop-shops where both API and drug product manufacturing from development through commercialization can be supported.
